Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1. Determination in primary breast cancer tissue for individualized therapy concepts. - Harbeck,N.; Schmitt,M.; Kate,R.E.; Kiechle,M.; Zemzoum,I.; Jänicke,F.; Thomssen,C. (Clinical Breast Cancer, 2002)